Erythropoietin Drugs Market Anticipated to Hit USD 8.17 billion by 2034, Expanding at a CAGR of 1.5%

Erythropoietin Drugs Market

The global erythropoietin drugs market size was valued at USD 7.02 billion in 2024. It is anticipated to generate an estimated revenue of USD 8.17 billion by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a CAGR of 1.5% over the forecasted timeframe, 2025-2034.

Market Overview

Erythropoietin (EPO) is a hormone that the kidneys essentially generate. It assists the body to sustain a healthy amount of red blood cells. There is also a lab-made configuration of erythropoietin that the healthcare providers utilize to cure anemia that arises from chronic kidney illness. Some athletes utilize this drug to enhance their performance as the EPO escalates the obtainability of oxygen to their muscles.

EPO stimulates the production of red blood cells. Red blood cells carry oxygen to the tissues in the body. Oxygen converts into energy, and the tissue releases carbon dioxide. The red blood cells also transfer carbon dioxide to the lungs so as to exhale. Usually, when specific cells in the kidneys inspect low blood oxygen levels, they escalate the generation of EPO. EPO then conveys the spongy tissue within the bones to create more red blood cells.

Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/erythropoietin-drugs-market/request-for-sample

Market Drivers

Growing Cases of Chronic Kidney Disease: The growing cases of chronic kidney disease (CKD) are pushing the demand for erythropoietin drugs. CKD frequently causes anemia because of the kidney's reduced potential to generate erythropoietin, a hormone important for red blood cell generation. In the US, more than 37 million people are impacted by CKD, as divulged by the Centers for Disease Control and Prevention (CDC) in 2021, placing the erythropoietin drugs market on a growth trajectory.

Rising Cancer Cases Globally: The growing aggregate of cancer cases worldwide assists in market growth. Cancer patients often advance anemia either as an instant outcome of the illness or a ramification of cure like chemotherapy-induced anemia.

Competitive Landscape

Critical to market strategy is the continuous instigation of innovative commodities using a gamut of technologies. Some of the companies which are currently dominating the market are:

• Amgen Inc.
• Biocon Limited
• Celltrion Inc.
• F. Hoffmann-La Roche Ltd.
• Intas Pharmaceuticals Ltd.
• Johnson & Johnson
• Kyowa Kirin Co., Ltd.
• Pfizer Inc.
• Swedish Orphan Biovitrum AB (Sobi)
• Teva Pharmaceutical Industries Ltd.

Inquire more about this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/erythropoietin-drugs-market/inquire-before-buying

Erythropoietin Drugs Market Report Highlights

📊 Based on application, the renal diseases segment dominated the market in 2024, owing to the widespread incidence of chronic kidney disease (CKD). This condition frequently causes anemia due to impaired erythropoietin production in damaged kidneys, creating substantial demand for EPO therapies.
📊 By type, biosimilars are witnessing significant growth due to patent expirations of biologic erythropoietin drugs and increasing demand for cost-effective treatment options. Regulatory support and expanding biosimilar adoption in emerging markets further drive this segment.
📊 In 2024, North America holds the largest share in the erythropoietin drugs market, primarily due to the high prevalence of chronic kidney disease (CKD) and cancer, which often lead to anemia requiring erythropoietin therapy.
📊 The Asia Pacific erythropoietin drugs market is witnessing significant growth, primarily due to the high prevalence of anemia and chronic kidney disease, especially in countries like India and China.

Geographical Landscape

The erythropoietin drugs market report offers detailed insights into the market landscape, which is further categorized into sub-regions and specific countries.
North America accounted for the largest share in 2024 due to the elevated existence of CKD and cancer, which frequently leads to anemia needing erythropoietin therapy.

Asia Pacific is poised to witness significant growth due to the elevated existence of anemia and chronic kidney disease (CKD), particularly in nations such as China and India.

Explore The Complete Report:
https://www.polarismarketresearch.com//industry-analysis/erythropoietin-drugs-market

Market Segmentation

Erythropoietin Drugs Market, Type Outlook (Revenue - USD Billion, 2020-2034)
• Biologics
• Biosimilars

Erythropoietin Drugs Market, Application Outlook (Revenue - USD Billion, 2020-2034)
• Cancer
• Renal Diseases
• Neurology
• Others

Erythropoietin Drugs Market, Product Outlook (Revenue - USD Billion, 2020-2034)
• Erythropoietin
• Darbepoetin-alfa

🔹 TOC:

1. Global Erythropoietin Drugs Market, by Type
1.1. Key Findings
1.2. Introduction
1.2.1. Global Erythropoietin Drugs Market, by Type, 2020-2034 (USD Billion)
1.3. Biologics
1.3.1. Global Erythropoietin Drugs Market, by Biologics, by Region, 2020-2034 (USD Billion)
1.4. Biosimilars
1.4.1. Global Erythropoietin Drugs Market, by Biosimilars, by Region, 2020-2034 (USD Billion)

2. Global Erythropoietin Drugs Market, by Product
2.1. Key Findings
2.2. Introduction
2.2.1. Global Erythropoietin Drugs Market, by Product, 2020-2034 (USD Billion)
2.3. Erythropoietin
2.3.1. Global Erythropoietin Drugs Market, by Erythropoietin, by Region, 2020-2034 (USD Billion)
2.4. Darbepoetin-alfa
2.4.1. Global Erythropoietin Drugs Market, by Darbepoetin-alfa, by Region, 2020-2034 (USD Billion)

More Trending Reports by Polaris Market Research:

Superdisintegrants Market:
https://www.polarismarketresearch.com/industry-analysis/superdisintegrants-market

Tendonitis Treatment Market:
https://www.polarismarketresearch.com/industry-analysis/tendonitis-treatment-market

Telerehabilitation Market:
https://www.polarismarketresearch.com/industry-analysis/telerehabilitation-market

Artificial Intelligence (AI) in Medical Diagnostics Market:
https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-ai-in-medical-diagnostics-market

Infantile Spasms Therapeutics Market:
https://www.polarismarketresearch.com/industry-analysis/infantile-spasm-therapeutics-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.